Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries
Authors:
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedeberg's Archives of Pharmacology
- Vol. 306 (1) , 101-103
Abstract
The effects of prostacyclin (PGI2) on vascular tension and cAMP content were measured in isolated bovine coronary artery strips. 3 nM PGI2 did not alter the tension but diminished the cAMP content by 56% of the control level (P2 diminished the tension and further reduced the cAMP content, which amounted to only 5% of the control at 300 nM PGI2. These results are in contrast to the increase in cAMP level by PGI2 in blood platelets and might indicate a different mechanism of action of PGI2 in platelets and vascular tissue.Keywords
This publication has 19 references indexed in Scilit:
- Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclinEuropean Journal of Pharmacology, 1978
- Prostacyclin is the major prostaglandin released from the isolated perfused rabbit and rat heartNature, 1977
- Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in plateletsNature, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Effects of peripheral and local administration of picrotoxin on the release of newly synthesized 3H-dopamine in the caudate nucleus of the catNaunyn-Schmiedeberg's Archives of Pharmacology, 1977
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- Effect of Phosphodiesterase-Inhibition on Smooth Muscle Tone1976
- Adenylcyclase-phosphodiesterase system in arterial smooth muscleLife Sciences, 1972
- CYCLIC AMP AND SMOOTH MUSCLE FUNCTION*Annals of the New York Academy of Sciences, 1971